FDA animal and veterinary recalls
Hospira recall: Buprenorphine Hydrochloride Injection Carpuject Units and Labetalol Hydrochloride Injection, USP…
Human medicine. A human medicine. It appears on the animal register because the recalling firm also makes animal products.
Quick answer
On 22 May 2024, US FDA published a recall of Buprenorphine Hydrochloride Injection Carpuject Units and Labetalol Hydrochloride Injection, USP Carpuject Units from Hospira. Reason: Device & Drug Safety – Potential Packaging Defect.
- Brand
- Hospira
- Company
- Hospira Inc.
- Product
- Buprenorphine Hydrochloride Injection Carpuject Units and Labetalol Hydrochloride Injection, USP Carpuject Units
- Reason
- Device & Drug Safety – Potential Packaging Defect
- Announced
- 22 May 2024
- Country
- United States
- Authority
- US FDA
- Status
- Listed
Which Hospira products are recalled?
Buprenorphine Hydrochloride Injection Carpuject Units and Labetalol Hydrochloride Injection, USP Carpuject Units, sold under Hospira.
Why was it recalled?
Device & Drug Safety – Potential Packaging Defect.
What should I do if I have it?
Stop feeding it and keep it away from pets and children. Keep the packaging and the receipt. If your pet has eaten it and seems unwell, call your vet. Most shops refund or replace recalled pet food.
Is this recall still active?
Yes. US FDA still lists it (checked 27 October 2026).
Where is the official notice?
On the US FDA website: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/hospira-inc-issues-voluntary-nationwide-recall-buprenorphine-hydrochloride-injection-carpujecttm
Taken from the notice US FDA published. It is not advice: the authority's own notice is what counts.
In English, briefly
Hospira Inc. announced a recall of Buprenorphine Hydrochloride Injection Carpuject Units and Labetalolol Hydrochloride Injection, USP Carpuject Units due to a potential packaging defect. The recall was announced on May 22, 2024.
Written by AI from the notice fields below. It can be wrong: the authority's own notice is what counts.
What changed
Added to FDA animal and veterinary recalls
Current values
- Announced
- 2024-05-22
- Announced display
- 05/22/2024
- Brand
- Hospira
- Company
- Hospira Inc.
- Product
- Buprenorphine Hydrochloride Injection Carpuject Units and Labetalol Hydrochloride Injection, USP Carpuject Units
- Reason
- Device & Drug Safety – Potential Packaging Defect
Version 1, captured 2026-09-02 10:43:30 UTC. sha256 fb5045a6d430972a437acff6947aef3dd360db774e7f1fc96870a6fc749263fc